Subacute sclerosing panencephalitis: Clinical aspects and prognosis: The brazilian registry

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 A, 1999, Pages 176-181

  Nunes, Magda Lahorgue ^a   Da Costa, Jaderson Costa ^a   Stancher, Vanessa M ^b   Diament, Aron ^c   Arita, Fernando ^d   Rosemberg, Sérgio ^d   Dyken, Paul ^e  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^e IRCND   (United States)

Author keywords

Immunization; Measles; Seizures; Subacute sclerosing panencephalitis

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BRAZIL; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MEASLES; PRESCHOOL CHILD; PROGNOSIS; REGISTER; SUBACUTE SCLEROSING PANENCEPHALITIS;

ADOLESCENT; ADULT; AGE FACTORS; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; MEASLES; PROGNOSIS; REGISTRIES; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0033146851     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000200002     Document Type: Article

References (14)

1. Dyken P. Subacute sclerosing panencephalitis:current status. Neurol Clin 1985;3:179-196
2. Dyken P. Subacute sclerosing panencephalitis. In Berg B (ed). Child neurology. New York: McGraw-Hill, 1996:859-868.
3. Gascon GG,Consortium director. International multicenter treatment study of inosiplex and alpha interferon in subacute sclerosing panencephalits. International SSPE Consortium Guidelines, June 13, 1996.
4. Ministério da Saúde - Brasil /Fundaçāo Nacional de Saúde/ Centro Nacional de Epidemiologia / Coordenaçāo Nacional de Doenças Imunopreveníveis. Boletim Epidemiológico (measles notification) 1991-1996.
5. Nunes ML, Da Costa JC, Da Silva LFG. Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis. Pediatr Neurol 1995;13:153-156.
6. Dyken P, Cunningham S. From the national SSPE registry. Neurology 1987;37:1883.
7. Dyken P, Cunningham S, Ward C. Changing character of Subacute sclerosing panencephalitis in the United States. Pediatric Neurology 1989;5:339-341.
8. Da Costa JC, Da Silva LFG, Nunes ML. Panencefalite esclerosante subaguda associada à gestaçào (SSPE associated with pregnancy). J Liga Bras Epilepsia (JLBE) 1991;4:17-21.
9. Moduli JF, Halsey NA, Eddins DL, et al. Epidemiology of subacute sclerosing panencephalitis. Pediatrics 1979;94:231-236.
10. Canelas HM, Lefévre AB, Tognola WA, et al. Subacute sclerosing leukoencephalitis: an epidemiological, clinical and biochemical study of 31 cases. Arq Neuropsiquiatr 1967;25:255-268.
11. Okuno Y, Nakao T, Ishida N, et al. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Internati J Epidemiol 1989;18:684-689.
12. Taylor WJ, DuRant RH, Dyken P. Treatment of subacute sclerosing panencephalitis: an overview. Drug Intell Clin Pharm 1984;18:377-381.
13. Yalaz K, Anlar B, Oktem F, et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992;42:488-491.
14. Thiel A, Nau R, Fischer F, et al. Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy. Neurology 1996;47:1604.